About ▼ Careers Internship MedBlog Contact us

LOGIN REGISTER

Medindia » News » Drug News » Beware of Cannabis - Not at all a mild drug

Beware of Cannabis - Not at all a mild drug

by Medindia Content Team on Jul 9 2006 9:34 AM

There is a whole lot of misconception about Cannabis and its effects. It is widely thought to be a mild medicine, not causing much harm. Such misrepresentations of the drug have resulted in making it a Class C drug.

However scientists from Karolinska Institute in Sweden have unearthed the harmful effects of cannabis, when they exposed rats to THC, a key causative ingredient in cannabis. It was found that the brain of those rats exposed to THC, got attuned to heroin, necessitating an increase in heroin intake during subsequent trials.

Cannabis is also linked to risks of cancer, schizophrenia, bipolar disorder and psychosis.

Recommended Readings

Iodine Deficiency Disorder

Iodine Deficiency Disorder

To control IDD, the ‘National Goiter Control Program (NGCP)’ was launched which was later renamed as the ‘National Iodine Deficiency Disorder Control Program (NIDDCP)’.

Drug Abuse

The use of Drugs for reasons other than its prescribed recommendation, is known as Drug abuse or substance abuse. Drug abuse or substance abuse is initiated by various biological and social factors.

Marijuana

Marijuana (cannabis) is a drug obtained from the hemp plant and often abused for its psychoactive effects, though it has medicinal uses as well.

Drug Toxicity

Drug toxicity is an adverse reaction of the body towards a drug that results as a side effect of a drug, reaction to a drug or drug abuse.

Cannabis

Cannabis has a long history of medicinal, recreational, and industrial use and comes from a bushy plant with thick sticky flowers called Cannabis Sativa

Latest Drug News

US FDA Approval of N-803: Ray of Hope For Bladder Cancer Patients

US FDA Approval of N-803: Ray of Hope For Bladder Cancer Patients

The US FDA approves a immunotherapy drug, N-803, for BCG-unresponsive non-muscle invasive bladder cancer, suggested to be used in conjunction with BCG.

Resmetirom For MASH: Approved by US FDA, Increase in Partnerships

Resmetirom For MASH: Approved by US FDA, Increase in Partnerships

The increasing trend in strategic partnerships between innovator companies, and the US FDA approval for Rezdiffra has led to a boost in the development of medications for MASH.

Semaglutide: A Dominant Player for Patients With Heart Failure

Semaglutide: A Dominant Player for Patients With Heart Failure

Data provesSemaglutideefficacy in treatment of Type 2 diabetes, obesity, heart failure, and chronic kidney failure, it emerges as important therapy in metabolic syndrome.

Physician's Lack Agreement – Patients Prefer Branded or Generic Drugs?

Physician's Lack Agreement – Patients Prefer Branded or Generic Drugs?

Generics are not widely used, despite cost advantage, due to a lack of information to patients and reluctance from physicians to prescribe generics - A Need to educate masses

Drug Resistant Melanoma Caused Due to Break in Genes!

Drug Resistant Melanoma Caused Due to Break in Genes!

Studies have led to discovery that drug-resistant melanomas are caused by breaks in the genes, thereby leading to emphasis on alternate targeted therapies to combat cancer.

Advertisement